Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-03
1999-02-09
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31505, A61K 31515
Patent
active
058694943
ABSTRACT:
Previously unknown anti-tumor, anti-infectious, immune system modulatory and anti-depressive properties of a family of barbituric acid derivatives are provided herein. Preferred derivatives are 4,6(1H, 5H)-pyrimidinedione, 1,3-dibutyldihydro-2thioxo; and 4,5,6(1H)-pyrimidinetrione, 1,3-dibutyldihydro-2thioxo. These compounds are effective for killing tumor cells, especially carcinoma, lymphoma and leukemia cells; for killing pathogenic organisms, especially viruses; for stimulating T cell formation and for alleviating symptoms of depression and are readily tolerated by the animal being treated.
REFERENCES:
patent: 3148189 (1964-09-01), Doran
patent: 3919232 (1975-11-01), Barer
patent: 3919427 (1975-11-01), Vida et al.
patent: 4292312 (1981-09-01), Griffon
patent: 4999344 (1991-03-01), Jett-Tilton et al.
patent: 5312919 (1994-05-01), Gulliya et al.
patent: 5382597 (1995-01-01), Boualam et al.
patent: 5514708 (1996-05-01), Rinehart et al.
patent: 5525626 (1996-06-01), Thornes et al.
patent: 5674870 (1997-10-01), Gulliya
Supplemental European Search Report mailed Apr. 6, 1988, for EP 9690549.2.
Kreutzberger, et al., "Butylderivate der 5-Aminomethylenbarbitursaure," Arch Pharm., 318(9):821-824, 1985.
Misra, et al., "Novel Pyrimidinediones and Thiazolidinones as Antidepressants," Boll Chim Farm., 134(9):492-496, 1995
Skehan, et al., "New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening," Journal of the National Cancer Institute, vol. 82, No. 13, pp. 1107-1112, Jul. 4, 1990.
Angst and Stabl, "Efficacy of Moclobemide in Different Patient Groups: A Meta-analysis of Studies," Psychopharmacology, 106:S109-S113, 1992.
Astwood et al., "Further Studies on the Chemical Nature of Compounds Which Inhibit the Function of the Thyroid Gland," Endocrinology, 37:456-481, Dec., 1945.
Beres et al., "Synthesis and Antibacterial Properties of Substituted Decylbarbituric Acids," Journal of Pharmaceutical Sciences, 63(3):469-471, 1974.
Beres et al., "Laboratory Note: Synthesis and Antibacterial Actvity of High Alkyl Barbituric Acids," Eur. J. Med. Chem.--Chimica Therapeutica, 15(6):571-573, 1980.
Boyer and Feighner, "Clinical Significance of Early Non-Response in Depressed Patients," Depression, 2:32-35, 1994.
Brown, D.J., "The Principal Synthetic Method," in The Pyrimidines, Interscience Publishers, a Division of John Wiley & Sons, Chapter II, Section 7, pp. 51-59, 1962.
Carter, Mary Kathleen, "The History of Barbituric Acid," Journal of Chemical Education, pp. 524-526, Oct., 1951.
Carter & Coffey, "The Prostate: An Increasing Medical Problem," The Prostate, 16:39-48, 1990.
Cohen et al. "Changes in Axon Fluorescence During Activity: Molecular Probes of Membrane Potential," J. Membrane Biol., 19(1-2):1-36, 1974.
Conrad and Guthzeit, Ueber Barbitursaure-derivate, Chem. Ber., 15:2844-2850, 1882.
Crumpacker II, Clyde S., "Molecular Targets of Antiviral Therapy," Seminars in Medicine of the Beth Israel Hospital, Boston, 321(3):163-172, 1989.
Deshpande and Datta, "Potential Antidiabetics 1-p-Toluene Sulphonyl-3 Alkyl (or Aryl) Barbituric Acid Derivatives," Indian J. Appl. Chem., 34(4-6):145-146, 1972.
Dinno et al., "Potency of Barbiturates in Inhibition of Frog Gastric Secretion," Proc. Soc. Exp. Biol. Med., 141:397-399, 1972.
Duvic, Madeleine, "Immunology of AIDS Related to Psoriasis," The Journal of Investigative Dermatology, 95(5):38S-40S, 1990.
Fischer and Merling, "Ueber eine neue Klasse von Schlafmitteln," Die Therapie der Genenwart, 44:97-101, 1903.
Frazer, Alan, "Antidepressant Drugs," Depression, 2:1-19, 1994.
Gittes, Ruben F., "Carcinoma of the Prostate," The New England Journal of Medicine, 324(4):236-245, 1991.
Gorter, G.J.M.A., "Comparative Effectiveness of Barbiturates for Systemic Control of Sphaerotheca Fuliginea (Schlecht. Ex Fries) Poll.," Phytophylactica, 2:145-146, 1969.
Gysling and Schwarzenbach, "Metallindikatoren II. Beziehungen Zwischen Struktur und Komplexbildungsvermogen bei Verwandten des Murexids," Helvetica Chimca Acta, Chpt. 199, 32(5):1484-1504, 1949.
Haefely, W.E., "GABA and the Anticonvulsant Action of Benzodiazepines and Barbiturates," Brain Research Bulletin, 5(Suppl. 2):873-878, 1980.
Hahn et al., "A Calcium-sensitive Fluorescent Analog of Calmodulin Based on a Novel Calmodulin-binding Fluorophore," The Journal of Biological Chemistry, 265(33):20335-20345, 1990.
Hamburger and Salmon, "Primary Bioassay of Human Myeloma Stem Cell," Journal of Clinical Investigation, 60:846-854, 1977.
Hirsch and Schooley, "Resistance to Antiviral Drugs: The End of Innocence," The New England Journal of Medicine, 320(5):313-314, 1989.
Kakemi et al., "Absorption and Excretion of Drugs," Chem. Pharm. Bull., 15:1534-1538, 1967.
Kreutzberger, Von A., "Tumorhemmende Wirkstoffe," Arzneim.-Forsch./Drug Res., 28:1684-1687, 1978.
Menter and Barker, "Psoriasis in Practice," The Lancet, 338:231-234, 1991.
Kamel, Mohsen M., "Barbituric Acid Derivatives," Pharmazie, 37:147, 1982.
Kauffman, George B., "Adolf von Baeyer and the Naming of Barbituric Acid," J. Chem. Educ., 57:222-223, 1980.
Kessel and Morgan, "Research Note. Photosensitization with a Chlorin-Thiobarbiturate Conjugate," Photochemistry and Photobiology, 59(5):547-549, 1994.
Kline and Hunninghake, "T-Lymphocyte Dysregulation in Asthma," Proc. Soc. Exp. Biol. and Med., 207:243-253, 1994.
Meyer and Rollet, "Barbituric Acid and Barbiturates," in Kirk-Opthmer Encycl. Chem. Technol., Second Edition, 3:60-77, 1964.
Robinson and Morgan, "Barbituric Acid Functionalized Porphyrins and Chlorins," Tetrahedron Letters, 34(23):3711-3714, 1993.
Sabata and Rout, "Influence of Structural Changes on Absorption in Merocyanines," J. Sci. Ind. Res. (India), 21:227-229, 1962.
Miller, et al., "Thiobarbiturates," J. Amer. Chem. Soc., 58:1090-1092, 1936.
Miller, et al., "Thiobarbiturates," Science, 81:616, 1935.,
Pollard and Luckert, "Promotional Effect of Sodium Barbiturate on Intestinal Tumors Induced in Rats by Dimethylhydrazine," J. Nat. Cancer Inst., 63(4):1089-1091, 1979.
Pyles et al., "Spectrophotometric Measurement of Plasma 2-Thiobarbituric Acid-Reactive Substances in the Presence of Hemoglobin and Bilirubin Interference," P.S.E.B.M., 202:407-419, 1993.
Rehse and Kapp, "3-(4-Amidinophenyl) -brenztraubensauren analoge 5-Amidinobenzylbarbitursauren," Arch. Pharm., 315:346-353, 1982.
Swinyard, "Sedatives and Hypnotics," in Remington's Pharmaceutical Science, 18th Edition, Mack Publishing Company, Chpt. 55, pp. 1057-1058 and 1063-1067, 1990.
Salmon et al., "Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs," N. Eng. J. Med., 298(24):1312-1327, 1978.
Schmidt, "Uber Thiobarbitursaure-Methin-Farbstoffe," Fette Seifer Anstrichmittel, 61:881-886, 1959.
Sheob et al., "Studies in Possible Oral Hypolycaemic Agents: Part VI-Synthesis of Some 2-& 4-Pyridylethyl Ureas & Thioureas & Some Barbiturates & Their Biological Acitivity," Indian J. Chem., 5:145-146, 1967.
Singh and Behl, 1-Aryl-5-arylazo-3 (o-chlorophenyl) -2thobarbituric Acids as Potential Antineoplastic Agents, Indian J. Chem., 19:625-626, 1980.
Sladowska, "1,3-Dicyclohexyl-5-Alkyl-5-Aminomethylbarbituric Acids as Potential Antiinflammatory Agents," Farmaco, Ed. Sci., 32(12):866-871, 1977.
Tabern and Volwiler, "Sulfur-Containing Barbiturate Hypnotics," J. Amer. Chem. Soc., 57:1961-1963, 1935.
Toth and Makleit, "Azido-Barbiturate, II," Acta Chimica Adacemiae Scientiarum Hungaricae, 107:147-153, 1981.
Vida et al., "Analgesica.3.Selected 1-Substitute and 1,3-Disubstituted 5-Propinoxy-5-(1-phenylethyl) barbituric Acids," J. Med. Chem., 18(7):694-696, 1975.
Vida et al., "Analgesics.2.Selected 5-Substituted 5-(1-Phenylethyl) barbituric Acids," J. Med. Chem., 17(11):1194-1197, 1974.
Vida et al., "Analgesics.1.Selected 5-Substituted 5-Propionoxybarbituric Acids," J. Med. Chem., 17(7):732-736, 1974.
Von Hoff et al., "Selection of Cancer Chemotherapy for a Patient by an In Vitro Assay Versus a Clinician," J. Natl. Cancer Inst., 82:110-116, 1990.
Von Hoff et al., "Prospective Clinical Trial of a Human Tumor Cloning System," Cancer Res., 43:1926-1931, 1983.
Von Hoff et al., "As
Kifle Bruck
Shah Mukund J.
LandOfFree
Uses for barbituric acid analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses for barbituric acid analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses for barbituric acid analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1948631